- Home
- Publications
- Publication Search
- Publication Details
Title
Marine-Derived Angiogenesis Inhibitors for Cancer Therapy
Authors
Keywords
-
Journal
Marine Drugs
Volume 11, Issue 12, Pages 903-933
Publisher
MDPI AG
Online
2013-03-16
DOI
10.3390/md11030903
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenstrom macroglobulinemia
- (2013) I. M. Ghobrial et al. BLOOD
- Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma
- (2013) V. Ribrag et al. HAEMATOLOGICA
- Newly discovered angiogenesis inhibitors and their mechanisms of action
- (2012) Ze-hong Miao et al. ACTA PHARMACOLOGICA SINICA
- Unusual expression of red fluorescence at M phase induced by anti-microtubule agents in HeLa cells expressing the fluorescent ubiquitination-based cell cycle indicator (Fucci)
- (2012) Asumi Honda-Uezono et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Plitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximab
- (2012) Nora M. Barboza et al. CANCER BIOLOGY & THERAPY
- Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors
- (2012) John H. Strickler et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase I trial of oral administration of panobinostat in combination with paclitaxel and carboplatin in patients with solid tumors
- (2012) Suzanne F. Jones et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Low-dose laulimalide represents a novel molecular probe for investigating microtubule organization
- (2012) Melissa J. Bennett et al. CELL CYCLE
- Resampling Phase III Data to Assess Phase II Trial Designs and Endpoints
- (2012) M. R. Sharma et al. CLINICAL CANCER RESEARCH
- Histone Deacetylase Inhibitors: New Promise in the Treatment of Immune and Inflammatory Diseases
- (2012) Stephen J. Shuttleworth et al. CURRENT DRUG TARGETS
- The Development of MetAP-2 Inhibitors in Cancer Treatment
- (2012) S.-Q. Yin et al. CURRENT MEDICINAL CHEMISTRY
- Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial
- (2012) Madeleine Duvic et al. EUROPEAN JOURNAL OF CANCER
- Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed
- (2012) Berkley E Gryder et al. Future Medicinal Chemistry
- Antibacterial efficacy of inhaled squalamine in a rat model of chronic Pseudomonas aeruginosa pneumonia
- (2012) S. Hraiech et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Panobinostat in Patients With Relapsed/Refractory Hodgkin's Lymphoma After Autologous Stem-Cell Transplantation: Results of a Phase II Study
- (2012) Anas Younes et al. JOURNAL OF CLINICAL ONCOLOGY
- Structural Analysis of Bengamide Derivatives as Inhibitors of Methionine Aminopeptidases
- (2012) Wei Xu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Shark cartilage: has the popularisation of science failed?
- (2012) Constantine Alifrangis et al. LANCET ONCOLOGY
- Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma
- (2012) Massimo Offidani et al. LEUKEMIA & LYMPHOMA
- Phase II trial of the pan-deacetylase inhibitor panobinostat as a single agent in advanced relapsed/refractory multiple myeloma
- (2012) Jeffrey L. Wolf et al. LEUKEMIA & LYMPHOMA
- The Alkaloid Ageladine A, Originally Isolated from Marine Sponges, Used for pH-Sensitive Imaging of Transparent Marine Animals
- (2012) Ulf Bickmeyer Marine Drugs
- Current Status on Marine Products with Reversal Effect on Cancer Multidrug Resistance
- (2012) Ioana Abraham et al. Marine Drugs
- The Antiangiogenic Compound Aeroplysinin-1 Induces Apoptosis in Endothelial Cells by Activating the Mitochondrial Pathway
- (2012) Beatriz Martínez-Poveda et al. Marine Drugs
- Fucoidan extract derived from Undaria pinnatifida inhibits angiogenesis by human umbilical vein endothelial cells
- (2012) Fang Liu et al. PHYTOMEDICINE
- FASCAPLYSIN as a Specific Inhibitor for CDK4: Insights from Molecular Modelling
- (2012) Muhammad Imtiaz Shafiq et al. PLoS One
- Anticancer Properties and Mechanisms of Fucoidan on Mouse Breast Cancer In Vitro and In Vivo
- (2012) Meilan Xue et al. PLoS One
- Incorporated nematocysts in Aeolidiella stephanieae (Gastropoda, Opisthobranchia, Aeolidoidea) mature by acidification shown by the pH sensitive fluorescing alkaloid Ageladine A
- (2012) Dana Obermann et al. TOXICON
- Squalamine and its derivatives as potential antitubercular compounds
- (2012) Brian T. Walker et al. TUBERCULOSIS
- Matrix metalloproteinases in vascular physiology and disease
- (2012) Suzanne A Siefert et al. Vascular
- New Proteasome Inhibitors in Myeloma
- (2012) Panisinee Lawasut et al. Current Hematologic Malignancy Reports
- Phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in patients with low or intermediate-1 risk myelodysplastic syndrome
- (2011) Sophie Dimicoli et al. AMERICAN JOURNAL OF HEMATOLOGY
- Arthrinins A–D: Novel diterpenoids and further constituents from the sponge derived fungus Arthrinium sp.
- (2011) Sherif S. Ebada et al. BIOORGANIC & MEDICINAL CHEMISTRY
- A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma
- (2011) John D. Hainsworth et al. CANCER INVESTIGATION
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- A phase I and pharmacokinetic study of plitidepsin in children with advanced solid tumours: An Innovative Therapies for Children with Cancer (ITCC) study
- (2011) Birgit Geoerger et al. EUROPEAN JOURNAL OF CANCER
- Fascaplysin exert anti-tumor effects through apoptotic and anti-angiogenesis pathways in sarcoma mice model
- (2011) Xiaojun Yan et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination
- (2011) Michael Millward et al. INVESTIGATIONAL NEW DRUGS
- Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel
- (2011) Michael Millward et al. INVESTIGATIONAL NEW DRUGS
- A One-Pot Synthesis and Biological Activity of Ageladine A and Analogues
- (2011) Sudhir R. Shengule et al. JOURNAL OF MEDICINAL CHEMISTRY
- Role of the Cytoskeleton in Formation and Maintenance of Angiogenic Sprouts
- (2011) Kayla J. Bayless et al. JOURNAL OF VASCULAR RESEARCH
- Plitidepsin Has a Safe Cardiac Profile: A Comprehensive Analysis
- (2011) Arturo Soto-Matos et al. Marine Drugs
- Mechanism of Action of Proteasome Inhibitors and Deacetylase Inhibitors and the Biological Basis of Synergy in Multiple Myeloma
- (2011) T. Hideshima et al. MOLECULAR CANCER THERAPEUTICS
- Phase II Study of Plitidepsin 3-Hour Infusion Every 2 Weeks in Patients With Unresectable Advanced Medullary Thyroid Carcinoma
- (2010) Eric Baudin et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Anti-microtubule ‘plinabulin’ chemical probe KPU-244-B3 labeled both α- and β-tubulin
- (2010) Yuri Yamazaki et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, synthesis, and biological evaluation of dibromotyrosine analogues inspired by marine natural products as inhibitors of human prostate cancer proliferation, invasion, and migration
- (2010) Asmaa A. Sallam et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS)
- (2010) N. Fortunati et al. BREAST CANCER RESEARCH AND TREATMENT
- Discovery and Characterization of the Laulimalide-Microtubule Binding Mode by Mass Shift Perturbation Mapping
- (2010) Melissa J. Bennett et al. CHEMISTRY & BIOLOGY
- Phase II Clinical and Pharmacokinetic Study of Plitidepsin 3-Hour Infusion Every Two Weeks Alone or with Dexamethasone in Relapsed and Refractory Multiple Myeloma
- (2010) M. V. Mateos et al. CLINICAL CANCER RESEARCH
- Phase 1 First-in-Human Trial of the Vascular Disrupting Agent Plinabulin(NPI-2358) in Patients with Solid Tumors or Lymphomas
- (2010) M. M. Mita et al. CLINICAL CANCER RESEARCH
- Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy
- (2010) D. Mottet et al. CURRENT CANCER DRUG TARGETS
- The marine compound spongistatin 1 targets pancreatic tumor progression and metastasis
- (2010) Andrea S. Rothmeier et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study
- (2010) Robert J. Morgan et al. INVESTIGATIONAL NEW DRUGS
- Antiangiogenic Metabolites from a Marine-Derived Fungus,Hypocrea vinosa
- (2010) Yuu Ohkawa et al. JOURNAL OF NATURAL PRODUCTS
- Reversal of TNP-470-Induced Endothelial Cell Growth Arrest by Guanine and Guanine Nucleosides
- (2010) J. Hines et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Chemoradiotherapy With or Without AE-941 in Stage III Non–Small Cell Lung Cancer: A Randomized Phase III Trial
- (2010) Charles Lu et al. JNCI-Journal of the National Cancer Institute
- Challenges to the development of bryostatin-type anticancer drugs based on the activation mechanism of protein kinase Cδ
- (2010) Kazuhiro Irie et al. MEDICINAL RESEARCH REVIEWS
- The odyssey of marine pharmaceuticals: a current pipeline perspective
- (2010) Alejandro M.S. Mayer et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant
- (2009) Paul M. Barr et al. AMERICAN JOURNAL OF HEMATOLOGY
- Cortistatin A is a High-Affinity Ligand of Protein Kinases ROCK, CDK8, and CDK11
- (2009) Victor J. Cee et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Pyripyropenes, Fungal Sesquiterpenes Conjugated with α-Pyrone and Pyridine Moieties, Exhibits Anti-angiogenic Activity against Human Umbilical Vein Endothelial Cells
- (2009) Asami Hayashi et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Direct effects of fascaplysin on human umbilical vein endothelial cells attributing the anti-angiogenesis activity
- (2009) Y.L. Zheng et al. BIOMEDICINE & PHARMACOTHERAPY
- Control of HIF-1 Expression by eIF2 Phosphorylation-Mediated Translational Repression
- (2009) K. Zhu et al. CANCER RESEARCH
- Antivascular Actions of Microtubule-Binding Drugs
- (2009) E. L. Schwartz CLINICAL CANCER RESEARCH
- Clinical Studies of Histone Deacetylase Inhibitors
- (2009) H. M. Prince et al. CLINICAL CANCER RESEARCH
- Phase II Randomized Study of Plitidepsin (Aplidin), Alone or in Association with L-carnitine, in Patients with Unresectable Advanced Renal Cell Carcinoma
- (2009) Patrick Schöffski et al. Marine Drugs
- Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma
- (2009) Tim Eisen et al. MELANOMA RESEARCH
- Emerging Treatments for Multiple Myeloma: Beyond Immunomodulatory Drugs and Bortezomib
- (2009) Constantine S. Mitsiades et al. SEMINARS IN HEMATOLOGY
- Evaluation of antiangiogenic activity of azumamides by the in vitro vascular organization model using mouse induced pluripotent stem (iPS) cells
- (2008) Yoichi Nakao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antitumour and antiangiogenic effects of Aplidin® in the 5TMM syngeneic models of multiple myeloma
- (2008) J Caers et al. BRITISH JOURNAL OF CANCER
- Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer
- (2008) Geoffrey Y. Ku et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Investigation of the marine compound spongistatin 1 links the inhibition of PKCα translocation to nonmitotic effects of tubulin antagonism in angiogenesis
- (2008) Andrea S. Rothmeier et al. FASEB JOURNAL
- Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer
- (2008) Tim Eisen et al. LUNG CANCER
- Streptopyrrolidine, an angiogenesis inhibitor from a marine-derived Streptomyces sp. KORDI-3973
- (2008) Hee Jae Shin et al. PHYTOCHEMISTRY
- The Marine-Derived Oligosaccharide Sulfate (MdOS), a Novel Multiple Tyrosine Kinase Inhibitor, Combats Tumor Angiogenesis both In Vitro and In Vivo
- (2008) Jingui Ma et al. PLoS One
- The marine lipopeptide somocystinamide A triggers apoptosis via caspase 8
- (2008) W. Wrasidlo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells
- (2007) Mee Young Ahn et al. GYNECOLOGIC ONCOLOGY
- Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancer
- (2007) Christian Peschel et al. LUNG CANCER
- A polysaccharide isolated from the brown seaweed Sargassum stenophyllum exerts antivasculogenic effects evidenced by modified morphogenesis
- (2007) Paulo Fernando Dias et al. MICROVASCULAR RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started